Factors like genetics, consistency, exercise, and medical history play a role
Canadians currently have access through clinical trial participation or research peptide suppliers while awaiting official approval
That problem is very real
Results indicate that GLP-1RA users, defined as those with a history of use exceeding six months and at least two refills within six months prior to the procedure, had a higher incidence rate of aspiration pneumonia (0.83%) compared to nonusers (0.63%), corresponding to a hazard ratio of 1.33
The Bottom Line for Patients Insurance coverage for weight loss medication in the United States is expanding, but unevenly, slowly, and with reversals along the way
Do not use GLP-1 medications if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)